{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:05:33Z","timestamp":1760015133946,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003971","name":"Islamic Development Bank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.025","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T08:31:24Z","timestamp":1558600284000},"page":"3562-3567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1669-1494","authenticated-orcid":false,"given":"Mohamed","family":"Tashani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-6435","authenticated-orcid":false,"given":"Al-Mamoon","family":"Badahdah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Alfelali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamah","family":"Barasheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6320-118X","authenticated-orcid":false,"given":"Amani S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Heron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Louth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-5139","authenticated-orcid":false,"given":"Harunor","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Booy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.025_b0005","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2174\/15680266113136660180","article-title":"Novel strategies for development of next-generation glycoconjugate vaccines","volume":"13","author":"Avci","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.vaccine.2019.05.025_b0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(09)61203-4","article-title":"Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates","volume":"374","author":"Watt","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.025_b0015","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.025_b0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.025_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.05.025_b0030","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection","volume":"30","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0035","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2019.05.025_b0040","unstructured":"Centers for Disease Control and Prevention. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997. MMWR Morb Mortal Wkly Rep. 1998;47:833\u20137."},{"key":"10.1016\/j.vaccine.2019.05.025_b0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jadohealth.2013.05.009","article-title":"Missed opportunities for adolescent vaccination, 2006\u20132011","volume":"53","author":"Wong","year":"2013","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.vaccine.2019.05.025_b0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.025_b0055","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.vaccine.2014.01.047","article-title":"Carrier priming or suppression: understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines","volume":"32","author":"Pobre","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0060","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.vaccine.2009.01.005","article-title":"The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants","volume":"27","author":"Pollabauer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0065","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/iai.61.2.432-438.1993","article-title":"Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components","volume":"61","author":"Barington","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.025_b0070","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/IAI.70.9.4946-4954.2002","article-title":"Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection","volume":"70","author":"Burrage","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.05.025_b0075","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/jama.1996.03530390048033","article-title":"Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia","volume":"275","author":"Mulholland","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.05.025_b0080","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1086\/420849","article-title":"Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria\/tetanus-conjugated vaccine: a randomized controlled trial","volume":"189","author":"Lucero","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0085","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.2013.228052","article-title":"Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial","volume":"310","author":"Spijkerman","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2019.05.025_b0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5409\/wjcp.v5.i3.311","article-title":"Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction","volume":"5","author":"Tashani","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"10.1016\/j.vaccine.2019.05.025_b0095","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/00365540110026502","article-title":"Low baseline antibody level to diphtheria is associated with poor response to conjugated pneumococcal vaccine in adults","volume":"33","author":"Shelly","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(11)70337-1","article-title":"Emergence of medicine for mass gatherings: lessons from the Hajj","volume":"12","author":"Memish","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0105","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/QCO.0b013e3282a64700","article-title":"Meningococcal vaccine in travelers","volume":"20","author":"Wilder","year":"2007","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0110","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0140-6736(06)68429-8","article-title":"Health risks at the Hajj","volume":"367","author":"Ahmed","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.025_b0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(02)07716-4","article-title":"W135 meningococcal disease in England and Wales associated with Hajj 2000 and 359 2001","author":"Hahne","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.025_b0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CVI.00314-12","article-title":"Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine","volume":"20","author":"Ceyhan","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.025_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay070","article-title":"Strengthening health security at the Hajj mass gatherings: a Harmonised Hajj Health Information System","volume":"25","author":"Yezli","year":"2018","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0135","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw087","article-title":"Strengthening health security at the Hajj mass gatherings: characteristics of the infectious diseases surveillance systems operational during the 2015 Hajj","volume":"24","author":"Alotaibi","year":"2017","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0140","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay068","article-title":"Preparing Australian pilgrims for the Hajj 2018","volume":"25","author":"Alqahtani","year":"2018","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0145","unstructured":"Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj), 2016. Wkly Epidemiol Rec. 2016;91:331\u20135."},{"key":"10.1016\/j.vaccine.2019.05.025_b0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tmaid.2013.06.001","article-title":"The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion","volume":"11","author":"Rashid","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijid.2016.02.005","article-title":"Exploring barriers to and facilitators of preventive measures against infectious diseases among Australian Hajj pilgrims: cross-sectional studies before and after Hajj","volume":"47","author":"Alqahtani","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.025_b0160","doi-asserted-by":"crossref","first-page":"5929","DOI":"10.1016\/j.vaccine.2016.10.020","article-title":"Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: a randomised controlled trial","volume":"34","author":"Tashani","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tax006","volume":"24","author":"Tashani","year":"2017","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0170","article-title":"Interaction of meningococcal conjugate vaccines with other conjugate or diphtheria-tetanus containing vaccines","volume":"25","author":"Badahdah","year":"2018","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0175","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.vaccine.2018.04.033","volume":"36","author":"Tashani","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0180","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook 10th ed (2015 update). Canberra: Australian Government Department of Health; 2015."},{"key":"10.1016\/j.vaccine.2019.05.025_b0185","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0190","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1016\/j.vaccine.2010.02.045","article-title":"Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines","volume":"28","author":"Arguedas","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0195","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.vaccine.2010.11.057","article-title":"Immunogenicity and reactogenicity of co-administered tetanus-diphtheria-acellular pertussis (Tdap) and tetravalent meningococcal conjugate (MCV4) vaccines compared to their separate administration","volume":"29","author":"Weston","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0200","first-page":"85","article-title":"Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease","volume":"7","author":"Hedari","year":"2014","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2019.05.025_b0205","unstructured":"Sanofi Pasteur Inc. 2018. Menactra\u00ae full prescribing information [Online]. Available from<https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm131170.pdf>. [accessed in March 2019]."},{"key":"10.1016\/j.vaccine.2019.05.025_b0210","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1016\/j.vaccine.2011.04.053","article-title":"Comparative effects of carrier proteins on vaccine-induced immune response","volume":"29","author":"Knuf","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0215","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3349\/ymj.2016.57.6.1511","article-title":"Immunogenicity of MenACWY-CRM in korean military recruits: influence of tetanus-diphtheria toxoid vaccination on the vaccine response to MenACWY-CRM","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.vaccine.2019.05.025_b0220","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/CVI.00267-16","article-title":"Immune responses in U.S. military personnel who received meningococcal conjugate vaccine (MenACWY) concomitantly with other vaccines were higher than in personnel who received MenACWY alone","volume":"23","author":"Broderick","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.05.025_b0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/INF.0b013e31816b4561","volume":"27","author":"Tejedor","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.05.025_b0230","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/iai.59.10.3504-3510.1991","article-title":"Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines","volume":"59","author":"Peeters","year":"1991","journal-title":"Infect Immun"},{"year":"2017","series-title":"Essential immunology","author":"Delves","key":"10.1016\/j.vaccine.2019.05.025_b0235"},{"key":"10.1016\/j.vaccine.2019.05.025_b0240","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1016\/j.vaccine.2010.06.026","article-title":"Glycoconjugate vaccines and immune interference: a review","volume":"28","author":"Dagan","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.025_b0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jtm.12180","article-title":"Immunogenicity and safety of concomitant administration of a combined hepatitis A\/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adults","volume":"22","author":"Alberer","year":"2014","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2019.05.025_b0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jtm.12164","article-title":"Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults","volume":"22","author":"Alberer","year":"2015","journal-title":"J Travel Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:32Z","timestamp":1759401212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":50,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X19306395"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}